• Home
  • About Journal
    Journal Introduction
    Editorial Board
    Youth Editorial Board
    Cooperating Institutions
    Editorial Department
  • Submission Guidelines
  • Policies & Statements
    Ethical Guidelines for Publication
    Academic Misconduct Statement
    Open Access (OA) Statement
    AIGC Use Statement
  • Journal Subscription
  • Download Center
  • 中文版
Cite this article:
ZHANG Yichi,ZHAO Xiaolin,WANG Xiaoyan,HAO Lina,WU Xuexin.TPMT gene polymorphism and 6-MP dividual therapy in children ALL[J].Journal Of Pharmaceutical Research,2017,36(10):609-613[Click to copy]
【Print this page】      【Download PDF Full Text】   【View/Add Comment】  【Download reader】  【 Close 】
←Previous|Next→ Archive    Advanced Search
This article has been viewed: 3700times   Download 3595次 QR Code for this article
Scan with your phone!
TPMT基因多态性与儿童ALL的6-MP个体化治疗
张一弛,赵孝林,王晓燕,郝丽娜,吴学新
Font:Larger+|Default|Smaller-
(济南市儿童医院药学部,山东 济南 250022)
摘要:
6-巯基嘌呤(6-MP)是儿童急性淋巴细胞白血病(ALL)维持治疗阶段的关键化疗药物。巯嘌呤甲基转移酶(TPMT)作为巯嘌呤类药物在体内代谢过程中的关键酶之一,其基因多态性及酶活性与急性淋巴细胞白血病患儿对6-巯基嘌呤的剂量耐受性有一定的相关性,从而进一步影响急性淋巴细胞白血病患儿服用6-巯基嘌呤后不良反应的发生程度和远期预后。此外,巯嘌呤甲基转移酶基因型也可能与继发恶性肿瘤有关。因此,检测巯嘌呤甲基转移酶酶活性或基因型,有助于预测巯嘌呤类药物不良反应的严重程度,及时调整给药剂量,制订安全合理的个体化用药方案。
关键词:  巯嘌呤甲基转移酶  基因多态性  6-巯基嘌呤  儿童急性淋巴细胞白血病  继发性恶性肿瘤
DOI:10.13506/j.cnki.jpr.2017.10.014
基金项目:
TPMT gene polymorphism and 6-MP dividual therapy in children ALL
ZHANG Yichi,ZHAO Xiaolin,WANG Xiaoyan,HAO Lina,WU Xuexin
(Department of Pharmacy,Children’s Hospital of Jinan,Jinan 250022,China)
Abstract:
6-mercaptopurine (6-MP) is a key drug for the maintainable treatment in childhood acute lymphoblastic leukemia (ALL).Thiopurine S-methyltransferase (TPMT) has been confirmed as one of the most distinctive enzymes,its gene polymorphisms and activity are associated with tolerance in ALL children which further affect the incidence of adverse reactions and long-term prognosis of ALL children with 6-MP. In addition,TPMT genotype may also be related to second malignant neoplasm (SMN).So detecting TPMT genotypes may be helpful to predict the severity of adverse reaction with thiopurine drugs, adjustment of the dosage in time, might make a safety and reasonable dividual medicine programs in clinical treatment.This article reviews the effect of TPMT gene polymorphism on the individual treatment of 6-MP in childhood ALL.
Key words:  Thiopurine methyltransferase  Genetic polymorphism  6-mercaptopurine  Childhood acute lymphocytic leukemia  Second malignant neoplasm
Today's Visits:464    Total Visits:2383159
Website copyright:Editorial Board of Journal of Pharmaceutical Research     鲁ICP备17018036号-3     鲁公网安备 37010202001351号
Sponsored by:Shandong Institute for Food and Drug Control Shandong Pharmaceutical Association Address:No.2749 Xinluo Street,High-Tech Zone,Jinan,P.R.China Postcode:250101
Telephone Number:0531-81216586 Email :yaoxueyanjiu@163.com;yaoxueyanjiu@126.com
Technical Support:Beijing Qinyun Technology Co., Ltd.